HealthcareGene variant influences risk for blood clots in COVID...

Gene variant influences risk for blood clots in COVID patients


Gene variant influences risk for blood clots in COVID patients
MBL2 haplotypes predict MBL activity in plasma and thromboembolic complications during intensive care. a, MBL activity across individual haplotype combinations. MBL activity in plasma at day 1 of intensive care was measured by a functional ELISA using a mannan matrix for MBL capture. Activity is expressed as a percentage of pooled normal human serum (NHS). The genetic variants shown in Table 1, rows 1–5 give rise to six major MBL2 haplotypes, which are denoted by their legacy names: HYA, LYA, LXA, HYD, LYB and LYC. The HYA, LYA and LXA haplotypes encode wild-type MBL protein and are referred to as ‘A’ haplotypes. The HYD, LYB and LYC haplotypes contain the missense variants referred to as the D, B or C alleles, respectively, and are shown together as ‘0’ haplotypes because they share a common deleterious effect on MBL activity. b, Haplotypes categorized according to MBL activity into high (HYA/HYA, LYA/LYA, HYA/LYA, HYA/LXA, LYA/LXA), intermediate (LXA/LXA, HYA/0, LYA/0) and deficient (LXA/0, 0/0). MBL activity differed significantly between the groups (230% (168–400, median and interquartile range) for the high group, 40% (24–70) for the intermediate group and 0.56% (0.00–1.25) for the deficient group; P Nature Immunology (2022). DOI: 10.1038/s41590-022-01227-w

A gene variant in the natural immune system influences the risk for blood clots in the lungs of severely ill COVID-19 patients. This has been documented in a new study by researchers at Uppsala University and Karolinska Institutet that has now been published in Nature Immunology.

“With this study, we are a step closer in explaining why COVID-19 patients have a substantially increased risk of ,” says Oskar Eriksson, medical doctor and researcher at Uppsala University and one of the article’s main authors.

It became apparent during the pandemic that patients with COVID-19 had a substantial increased risk of suffering blood clots, even when treated with . Why COVID-19 leads to such a major activation of the blood’s coagulation system in some patients is not yet clear. Researchers at Uppsala University and Karolinska Institutet have now discovered that a , which regulates the levels of the protein mannose-binding lectin in the blood, protects against blood clots in the lungs.

Recognizes the coronavirus

Mannose-binding lectin is part of the natural immune system. It discovers and eliminates cells infected by bacteria and viruses. Another recent study (Stravalaci et al. Nature Immunology volume 23, pages 275–286 (2022)) showed that mannose-binding lectin recognizes the SARS-CoV-2 virus that causes COVID-19 and can neutralize cells infected with the virus.

“We can now show how mannose-binding lectin influences the course of the illness COVID-19. It is striking that it is the risk for blood clots that is impacted, and we could not see that mannose-binding lectin influences the risk of becoming ill with COVID-19. We can show that the is important for blood clot formation in COVID-19 patients, something that was long suspected and that can explain why such high doses of blood thinners have been necessary,” says Oskar Eriksson.

“The large studies that have been presented in the last year have identified several gene variants that influence the risk of becoming severely ill from COVID-19. Our work shows that there is also a genetic background for which complications affect COVID-19 patients,” says Hugo Zeberg, medical doctor and researcher at Karolinska Institutet and co-responsible for the study.


Possible blood-clotting mechanism in COVID-19 found


More information:
Michael Hultström et al, Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19, Nature Immunology (2022). DOI: 10.1038/s41590-022-01227-w

Provided by
Uppsala University


Citation:
Gene variant influences risk for blood clots in COVID patients (2022, May 30)
retrieved 30 May 2022
from https://medicalxpress.com/news/2022-05-gene-variant-blood-clots-covid.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Original Source Link

Latest News

Prince Joseph Olaniyan: Revolutionizing Fashion and Redefining Style

New York Fashion Week 2025 wasn’t just a runway spectacle – it was a revolution. And at the heart...

Employees are in an engagement crisis and 79% say they’ve detached from their job

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms...

Ether reserves on exchanges hit 9-year low as supply shrinks

Diminishing Ether supply on exchanges may signal an incoming price rally driven by a “supply shock,” which occurs...

DJI’s new Osmo Mobile 7 Pro has so very many tricks up its sleeve

Personally, I can’t imagine using my smartphone as a baby steadicam anymore now that I have DJI’s Osmo...

Lawrence O’Donnell Sounds The Alarm On Elon Musk’s Threat To Social Security

PoliticusUSA is independent, ad-free, and solely supported by our readers. Please support us by becoming a subscriber.MSNBC’s Lawrence...

Must Read

'People-focused' community in Fort Bend County in high demand, developers say

Meristem Communities says its first project's focus on...

The Deal with Eric Adams is NOT a “Plea Bargain”

In response to my earlier post about the...
- Advertisement -

You might also likeRELATED
Recommended to you